QUADRANT CAPITAL GROUP LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 168 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$91,055
+28.7%
1,7390.0%0.01%
+16.7%
Q1 2024$70,743
-43.9%
1,739
-49.1%
0.01%
-45.5%
Q4 2023$126,182
+18.4%
3,414
+22.4%
0.01%0.0%
Q3 2023$106,578
+10.7%
2,790
+4.6%
0.01%
+10.0%
Q2 2023$96,235
+143.7%
2,668
+158.0%
0.01%
+150.0%
Q1 2023$39,489
-27.7%
1,034
+7.7%
0.00%
-33.3%
Q4 2022$54,624
+203.5%
960
+111.5%
0.01%
+200.0%
Q3 2022$18,000
-10.0%
454
+0.4%
0.00%
-33.3%
Q2 2022$20,000
+42.9%
452
+25.9%
0.00%
+50.0%
Q1 2022$14,000
+55.6%
359
+56.1%
0.00%
+100.0%
Q4 2021$9,000
+50.0%
230
+46.5%
0.00%0.0%
Q3 2021$6,0000.0%157
+26.6%
0.00%0.0%
Q2 2021$6,000
+20.0%
124
+2.5%
0.00%0.0%
Q1 2021$5,0000.0%121
+12.0%
0.00%0.0%
Q4 2020$5,000
+66.7%
1080.0%0.00%0.0%
Q3 2020$3,0000.0%108
+14.9%
0.00%0.0%
Q2 2020$3,000
-91.7%
94
-95.4%
0.00%
-83.3%
Q1 2020$36,000
+2.9%
2,053
+0.5%
0.01%
+50.0%
Q4 2019$35,000
+483.3%
2,042
+476.8%
0.00%0.0%
Q4 2015$6,0003540.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders